Search research articles
Contact Us
Filters
Showing results (51-60 of 199) with videos related to
Page
of 20
Sort By:
British Journal of Cancer
|
October 1, 1983
The role of dexamethasone in the modification of misonidazole pharmacokinetics
D H Jones, N M Bleehen, P Workman, et al.
Journal of Cosmetic Science
|
May 12, 2006
Availability and chemical composition of traditional eye cosmetics ("kohls") used in the United Arab Emirates of Dubai, Sharjah, Ajman, Umm Al-Quwain, Ras Al-Khaimah, and Fujairah
Andrew D Hardy, Richard I Walton, Kathryn A Myers, et al.
Angewandte Chemie (International Ed. in English)
|
April 22, 2008
Structural effects of solvents on the breathing of metal-organic frameworks: an in situ diffraction study
Franck Millange, Christian Serre, Nathalie Guillou, et al.
The British Journal of Radiology
|
February 1, 1986
A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics
J T Roberts, N M Bleehen, M I Walton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1984
A phase I study of the hypoxic cell radiosensitizer Ro-03-8799
J T Roberts, N M Bleehen, P Workman, et al.
Biochemical Pharmacology
|
March 1, 1983
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism
P Workman, P R Twentyman, F Y Lee, et al.
Acta Crystallographica. Section C, Structural Chemistry
|
March 4, 2017
The ambient hydration of the aluminophosphate JDF-2 to AlPO-53(A): insights from NMR crystallography
Daniel M Dawson, Richard I Walton, Stephen Wimperis, et al.
Cancer Research
|
January 20, 2004
The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway
Steven R Whittaker, Mike I Walton, Michelle D Garrett, et al.
Chemical Communications (Cambridge, England)
|
April 1, 2006
An EXAFS study of the formation of a nanoporous metal-organic framework: evidence for the retention of secondary building units during synthesis
Suzy Surblé, Franck Millange, Christian Serre, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 1998
Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancer
C P Cottrill, K Bishop, M I Walton, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 199) with videos related to
Sort By:
Page
of 20
British Journal of Cancer
|
October 1, 1983
The role of dexamethasone in the modification of misonidazole pharmacokinetics
D H Jones, N M Bleehen, P Workman, et al.
Journal of Cosmetic Science
|
May 12, 2006
Availability and chemical composition of traditional eye cosmetics ("kohls") used in the United Arab Emirates of Dubai, Sharjah, Ajman, Umm Al-Quwain, Ras Al-Khaimah, and Fujairah
Andrew D Hardy, Richard I Walton, Kathryn A Myers, et al.
Angewandte Chemie (International Ed. in English)
|
April 22, 2008
Structural effects of solvents on the breathing of metal-organic frameworks: an in situ diffraction study
Franck Millange, Christian Serre, Nathalie Guillou, et al.
The British Journal of Radiology
|
February 1, 1986
A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics
J T Roberts, N M Bleehen, M I Walton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1984
A phase I study of the hypoxic cell radiosensitizer Ro-03-8799
J T Roberts, N M Bleehen, P Workman, et al.
Biochemical Pharmacology
|
March 1, 1983
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism
P Workman, P R Twentyman, F Y Lee, et al.
Acta Crystallographica. Section C, Structural Chemistry
|
March 4, 2017
The ambient hydration of the aluminophosphate JDF-2 to AlPO-53(A): insights from NMR crystallography
Daniel M Dawson, Richard I Walton, Stephen Wimperis, et al.
Cancer Research
|
January 20, 2004
The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway
Steven R Whittaker, Mike I Walton, Michelle D Garrett, et al.
Chemical Communications (Cambridge, England)
|
April 1, 2006
An EXAFS study of the formation of a nanoporous metal-organic framework: evidence for the retention of secondary building units during synthesis
Suzy Surblé, Franck Millange, Christian Serre, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 1998
Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancer
C P Cottrill, K Bishop, M I Walton, et al.
Page
of 20